glp 1 agonists and anesthesia GLP-1 Anesthesia: Considerations and Cautions for CRNAs GLP-1 drugs and aspiration risk

Davidson J

Combined analysis of three large inter- ventional trials with gliptins indicates increased incidence of acute pancreatitis in patients with type 2 diabetes

learn more about another GLP-1 alternative, a probiotic called Akkermansia for weight loss

The data showing cagrilintide preferentially reduces fat mass while preserving lean mass is compelling for researchers who care about body composition, not just the scale number

The remaining 9 agents are primarily investigative: survodutide (n = 345), JNJ-64565111 (n = 295), beinaglutide (n = 286), retatrutide (n = 268), efpeglenatide (n = 235), orforglipron (n = 222), noiiglutide (n = 192), mazdutide (n = 186), and exenatide (n = 114)